Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Astrocyte response to IFN-γ limits IL-6-mediated microglia activation and progressive autoimmune encephalomyelitis.
Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases.
IL-27-induced modulation of autoimmunity and its therapeutic potential.
Use of a physiological profile to document motor impairment in ageing and in clinical groups.
Risk Knowledge in Relapsing Multiple Sclerosis (RIKNO 1.0) - Development of an Outcome Instrument for Educational Interventions.
Opening locked doors: Integrating a palliative care approach into the management of patients with severe multiple sclerosis.
Complement receptor 2 is up regulated in the spinal cord following nerve root injury and modulates the spinal cord response.
Schwann Cell Expressed Nogo-B Modulates Axonal Branching of Adult Sensory Neurons Through the Nogo-B Receptor NgBR.
Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study.
Origins of oligodendrocytes in the cerebellum, whose development is controlled by the transcription factor, Sox9.
Kif13b Regulates PNS and CNS Myelination through the Dlg1 Scaffold.
Health-related quality of life among latinos with multiple sclerosis.
Association of Epstein-Barr virus infection with multiple sclerosis in India.
Increased carbonylation, protein aggregation and apoptosis in the spinal cord of mice with experimental autoimmune encephalomyelitis.
Timed 25-Foot Walk: Direct evidence that improving 20% or greater is clinically meaningful in MS.
DTI Measurements in Multiple Sclerosis: Evaluation of Brain Damage and Clinical Implications.
Mode of action and clinical studies with fumarates in multiple sclerosis.
Multiple sclerosis: The elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1.
Glutamate Release Machinery Is Altered in the Frontal Cortex of Rats with Experimental Autoimmune Encephalomyelitis.
A rare case of Balo concentric sclerosis showing unusual clinical improvement and response with oral prednisolone.
Advances in understanding the pathogenesis of autoimmune disorders: focus on chemokines and lymphocyte trafficking.
Clinical experience with THC:CBD oromucosal spray in patients with multiple sclerosis-related spasticity.
A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort.
Multiple sclerosis in pregnancy.
A case of IgM paraproteinemic neuropathy associated with anti-sulfated glucuronic paragloboside (SGPG) IgG antibody without anti-myelin-associated glycoprotein (MAG) activity.
Pages
« first
‹ previous
…
495
496
497
498
499
500
501
502
503
…
next ›
last »